Medicare Part D coverage · glycopyrrolate · RxCUI 999961
glycopyrrolate 0.2 MG/ML Oral Solution
Per the CMS 2026 Part D formulary file, glycopyrrolate 0.2 MG/ML Oral Solution is covered by 854 Medicare Part D plans (16.9% of enrollable products), averaging Tier 2.2, with prior authorization required on 2.4% of covering formularies.
- 16.9%
- Plan coverage
- 854
- Plans covering
- T2.2
- Avg tier
- 2.4%
- Prior auth required
What the CMS Formulary Data Shows for glycopyrrolate 0.2 MG/ML Oral Solution
Per the CMS 2026 Part D formulary file, glycopyrrolate 0.2 MG/ML Oral Solution (RxNorm concept RXCUI 999961, generic name glycopyrrolate) appears on 42 distinct formulary files spanning 854 Medicare Part D plan offerings - 16.9% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.2.
Real-world access to glycopyrrolate 0.2 MG/ML Oral Solution depends on utilization management as much as tier placement: 2.4% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 51,524 Part D beneficiaries filled glycopyrrolate 0.2 MG/ML Oral Solution in 2023, with total plan-and-beneficiary spending of $11,614,817 and an average per-beneficiary annual cost of $225.43. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry glycopyrrolate 0.2 MG/ML Oral Solution today.
Coverage Details
- Formularies covering
- 42
- Plans covering
- 854
- Coverage rate
- 16.9%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 2.4% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 51,524
- Total spending
- $11,614,817
- Avg per beneficiary
- $225.43
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering glycopyrrolate 0.2 MG/ML Oral Solution
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | No | $0 | MA |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | No | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | No | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | No | $0 | CA |
| Abilis Health Community (HMO I-SNP) | Signature Advantage, LLC | T1 | No | $0 | KY, TN |
| Arkansas Integrated Providers (AIP) Dual Advantage (HMO D-SNP) | Arkansas Superior Select, Inc. | T1 | No | $0 | AR |
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | No | $0 | WI |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Tufts Health One Care (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health One Care CW (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options CW (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| American Health Advantage of Florida (HMO I-SNP) | American Health Plan OF FL, Inc. | T1 | No | $4.80 | FL |
| Texas Independence Health Plan, Inc. (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | No | $4.80 | TX |
| Texas Independence Community Plan (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | No | $4.80 | TX |
| Tribute Select (HMO-POS I-SNP) | Arkansas Superior Select, Inc. | T1 | No | $8.90 | AR |
| American Health Advantage of Mississippi (HMO I-SNP) | American Health Plan OF MS, Inc. | T1 | No | $23.80 | MS |
| Georgia Health Advantage (HMO I-SNP) | Georgia Assurance, Inc. | T1 | No | $25.40 | GA |
| Georgia Health Advantage Choice (HMO I-SNP) | Georgia Assurance, Inc. | T1 | No | $25.40 | GA |
Show the next 30 plans
| American Health Advantage of Tennessee (HMO I-SNP) | American Health Plan, Inc. | T1 | No | $27.70 | TN |
| American Health Advantage of Oklahoma (HMO I-SNP) | Oklahoma Superior Select, Inc. | T1 | No | $28.20 | OK |
| Valor Health Plan (HMO I-SNP) | TSG Guard, Inc. | T1 | No | $31.40 | OH |
| American Health Advantage of Pennsylvania (HMO I-SNP) | American Health Plan OF Pennsylvania Inc | T1 | No | $32.70 | PA |
| WV Senior Advantage (HMO I-SNP) | West Virginia Senior Advantage, Inc. | T1 | No | $32.70 | WV |
| American Health Advantage of Louisiana (HMO I-SNP) | Dignity Care Corporation | T1 | No | $32.90 | LA |
| Abilis Health (HMO I-SNP) | Signature Advantage, LLC | T1 | No | $35.90 | KY, TN |
| American Health Advantage of Utah (HMO I-SNP) | American Health Plan OF UT, Inc. | T1 | No | $37.60 | UT |
| American Health Advantage of Idaho (HMO I-SNP) | American Health Plan OF UT, Inc. | T1 | No | $37.60 | ID |
| American Health Advantage of Indiana (HMO I-SNP) | American Health Plan OF Indiana Inc | T1 | No | $38.40 | IN |
| CommuniCare Advantage ISNP (HMO I-SNP) | OH CHS SNP Inc. | T1 | No | $38.40 | IN, MD, OH |
| Iowa Health Advantage (HMO I-SNP) | American Health Plan OF Iowa Inc | T1 | No | $41.50 | IA |
| Iowa Health Advantage Choice (HMO I-SNP) | American Health Plan OF Iowa Inc | T1 | No | $41.50 | IA |
| American Health Advantage of Missouri (HMO I-SNP) | American Health Plan OF Missouri, Inc. | T1 | No | $43.00 | MO |
| American Health Advantage of Missouri Choice (HMO I-SNP) | American Health Plan OF Missouri, Inc. | T1 | No | $43.00 | MO |
| Kansas Health Advantage (HMO I-SNP) | Kansas Superior Select, Inc. | T1 | No | $55.20 | KS |
| Kansas Health Advantage Choice (HMO I-SNP) | Kansas Superior Select, Inc. | T1 | No | $55.20 | KS |
| MCS Classicare RxMax (HMO) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Platino Ideal (HMO D-SNP) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Efectivo (HMO) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Essential (HMO-POS) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Platino Progreso (HMO D-SNP) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Primero (HMO C-SNP) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Firme (HMO) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare En Tu Hogar (HMO) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Hero (HMO) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Platino Total (HMO D-SNP) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare InteliCare (HMO) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Platino Maximo (HMO D-SNP) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Excede (HMO) | MCS Advantage, Inc. | T2 | No | $0 | PR |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is glycopyrrolate 0.2 MG/ML Oral Solution covered by Medicare Part D?
Yes, glycopyrrolate 0.2 MG/ML Oral Solution is covered by 854 Medicare Part D plans (16.9% of all Part D formularies).
What tier is glycopyrrolate 0.2 MG/ML Oral Solution on Medicare Part D plans?
glycopyrrolate 0.2 MG/ML Oral Solution averages Tier 2.2 across Part D plans, ranging from Tier 1 to Tier 4.
Does glycopyrrolate 0.2 MG/ML Oral Solution require prior authorization?
2.4% of Part D formularies require prior authorization for glycopyrrolate 0.2 MG/ML Oral Solution. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on glycopyrrolate 0.2 MG/ML Oral Solution?
In 2023, total Medicare Part D spending on glycopyrrolate 0.2 MG/ML Oral Solution was $11,614,817, covering 51,524 beneficiaries. The average spend per beneficiary was $225.43.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 0.5 ML meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML Prefilled Syringe [Bexsero] T2.2
- BCG, live, Tice strain 50 MG Injection T2.2
- glimepiride 1 MG Oral Tablet T2.2
- megestrol acetate 40 MG Oral Tablet T2.2
- permethrin 50 MG/ML Topical Cream T2.2
- poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Suspension [Ipol] T2.2
Similar prior-authorization rate
- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler [Atrovent] 2.4% PA
- felbamate 120 MG/ML Oral Suspension 2.4% PA
- 20 ML potassium chloride 2 MEQ/ML Injection 2.4% PA
- digoxin 0.25 MG Oral Tablet 2.4% PA
- 2.4 ML aripiprazole 300 MG/ML Prefilled Syringe [Abilify] 2.3% PA
- 3.2 ML aripiprazole 300 MG/ML Prefilled Syringe [Abilify] 2.3% PA